Rep. Jefferson Shreve Sells The Clorox Company (NYSE:CLX) Shares

Representative Jefferson Shreve (R-Indiana) recently sold shares of The Clorox Company (NYSE:CLX). In a filing disclosed on May 08th, the Representative disclosed that they had sold between $15,001 and $50,000 in Clorox stock on April 11th. The trade occurred in the Representative’s “CRT – STANDARD UNIT TRUST” account.

Representative Jefferson Shreve also recently made the following trade(s):

• Purchased $50,001 – $100,000 in shares of Chipotle Mexican Grill (NYSE:CMG) on 4/17/2025.
• Purchased $50,001 – $100,000 in shares of Applied Materials (NASDAQ:AMAT) on 4/17/2025.
• Purchased $15,001 – $50,000 in shares of Caterpillar (NYSE:CAT) on 4/17/2025.
• Sold $15,001 – $50,000 in shares of Lululemon Athletica (NASDAQ:LULU) on 4/17/2025.
• Purchased $15,001 – $50,000 in shares of Western Digital (NASDAQ:WDC) on 4/17/2025.
• Sold $15,001 – $50,000 in shares of Zoetis (NYSE:ZTS) on 4/17/2025.
• Purchased $15,001 – $50,000 in shares of Stryker (NYSE:SYK) on 4/17/2025.
• Purchased $15,001 – $50,000 in shares of NextEra Energy (NYSE:NEE) on 4/17/2025.
• Purchased $15,001 – $50,000 in shares of CSX (NASDAQ:CSX) on 4/17/2025.
• Purchased $15,001 – $50,000 in shares of Ross Stores (NASDAQ:ROST) on 4/17/2025.

Clorox Trading Down 2.2 %

NYSE:CLX opened at $134.79 on Friday. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The business’s 50-day simple moving average is $142.37 and its 200 day simple moving average is $154.07. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The stock has a market cap of $16.60 billion, a price-to-earnings ratio of 36.83, a price-to-earnings-growth ratio of 2.62 and a beta of 0.60.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.12). The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. Clorox had a net margin of 6.38% and a return on equity of 316.87%. The company’s revenue was down 8.0% on a year-over-year basis. During the same period in the prior year, the company earned $1.71 earnings per share. As a group, sell-side analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd were given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.62%. The ex-dividend date was Wednesday, April 23rd. Clorox’s payout ratio is 87.61%.

Insiders Place Their Bets

In other news, Director Pierre R. Breber acquired 4,000 shares of the company’s stock in a transaction dated Wednesday, May 7th. The shares were bought at an average price of $136.57 per share, with a total value of $546,280.00. Following the purchase, the director now owns 4,000 shares of the company’s stock, valued at approximately $546,280. This represents a ? increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.57% of the stock is currently owned by insiders.

Institutional Trading of Clorox

Large investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its stake in shares of Clorox by 0.4% in the first quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company’s stock worth $2,293,135,000 after purchasing an additional 65,924 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of Clorox by 2.3% in the 4th quarter. Geode Capital Management LLC now owns 3,098,302 shares of the company’s stock worth $501,925,000 after acquiring an additional 69,969 shares during the period. Stifel Financial Corp boosted its holdings in shares of Clorox by 0.4% in the fourth quarter. Stifel Financial Corp now owns 2,344,408 shares of the company’s stock valued at $380,761,000 after acquiring an additional 9,582 shares in the last quarter. Norges Bank acquired a new position in shares of Clorox during the fourth quarter valued at approximately $259,041,000. Finally, Northern Trust Corp raised its holdings in Clorox by 18.2% during the fourth quarter. Northern Trust Corp now owns 1,494,265 shares of the company’s stock worth $242,684,000 after purchasing an additional 230,173 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CLX has been the subject of several research analyst reports. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a report on Thursday, January 30th. JPMorgan Chase & Co. dropped their price target on Clorox from $151.00 to $144.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 6th. DA Davidson decreased their price objective on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a report on Wednesday, February 5th. Barclays dropped their target price on shares of Clorox from $134.00 to $129.00 and set an “underweight” rating on the stock in a report on Wednesday. Finally, Citigroup decreased their price target on shares of Clorox from $165.00 to $150.00 and set a “neutral” rating for the company in a report on Monday, April 14th. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $151.23.

About Representative Shreve

Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana’s 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana’s 6th Congressional District. He declared candidacy for the 2026 election.

Email [email protected] to notify us of updates to this biography.
Jefferson Shreve earned a bachelor’s degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve’s career experience includes working as a real estate executive.

Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.